Gene Query: INTS6L

Dataset Description Geneva Score
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 33.68
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 25.71
Gene expression changes associated with resistance to tagraxofusp (SL-401) 21.0
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 20.61
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 20.54
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 17.02
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 17.02
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 16.98
Gene expression profile of human iPSC-derived nephron progenitor cells 16.06
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 15.98
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 15.97
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 15.92
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 15.92
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 15.74
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 14.5
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 13.81
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 13.64
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 13.04
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 12.2
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 11.92
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 11.76
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 11.76
Transcriptional profiles of normal human mature B cells 11.42
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 10.65
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 10.61
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 10.61
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 10.34
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 10.3
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 10.28
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 9.87
Identification of Atrial Fibrillation associated genes and functional non-coding variants 9.36
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 9.28
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 8.91
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 8.69
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 8.14
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 8.09
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 7.99
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 7.98
Noncoding regions are the main source of targetable tumor-specific antigens 7.98
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 7.9
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 7.74
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 7.71
Dynamic reorganization of nuclear architecture during human cardiogenesis 7.66
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 7.66
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 7.6
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.43
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 7.39
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.36
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.36
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 7.27
Human HAP1 cells before and after nutrient deprivation 7.27
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.07
LncRNA expression profiling of ischemic stroke patients 6.99
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 6.96
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 6.88
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 6.88
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 6.87
The pioneer factor CEBPA modulates vitamin D signaling 6.87
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 6.87
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 6.84
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 6.76
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 6.67
Intrahepatic MAIT cell gene expression revealed by RNA-seq 6.66
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 6.48
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 6.47
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 6.46
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 6.42
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 6.42
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 6.41
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 6.37
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 6.1
The landscape of alternative splicing in aggressive prostate cancers 6.09
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 6.05
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 6.05
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.95
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 5.95
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 5.95
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 5.92
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 5.91
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 5.8
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 5.73
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.58
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 5.57
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.46
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 5.44
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 5.43
BACH2 in human plasma cell fate decision 5.38
iPSC-Derived Cholangiocytes 5.26
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 5.24
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 5.14
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 5.12
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.03
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.03
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 4.89
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 4.89
ChIP-seq and RNA-seq from human lymphoma cell lines 4.89
RNA-seq data from human lymphoma cell lines 4.89
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 4.88
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 4.71
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 4.71
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 4.7
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 4.7
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 4.68
Polarized B -cell functions 4.66
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 4.65
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 4.65
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 4.63
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 4.62
Oncogenic MYC induces a dependency on the spliceosome in human cancer 4.6
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 4.57
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 4.56
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 4.55
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 4.53
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 4.47
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 4.44
Gene expression in PANC1 cells treated with Rakicidin 4.44
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 4.4
Gene expression changes after LOC550643 silencing 4.37
Genome-wide discovery of human splicing branchpoints 4.35
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 4.34
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 4.34
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 4.3
HNRNPL and its RNA Targets in Prostate Cancer 4.3
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 4.29
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 4.26
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 4.26
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 4.24
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.23
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 4.2
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 4.2
RNA-seq analysis of differentiating human erythroblasts 4.13
quanTIseq: quantifying immune contexture of human tumors 4.09
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 4.04
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 4.01
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 4.0
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 4.0
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 3.97
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 3.94
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 3.92
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.91
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 3.9
Tracking of dCas9-methyltransferase footprints 3.9
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 3.9
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 3.86
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.83
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.83
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 3.81
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 3.79
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 3.74
Bone marrow derived human B cells [normal proB] 3.72
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.71
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 3.71
Non-coding regions are the main source of tumor-specific antigens [human] 3.7
Non-coding regions are the main source of tumor-specific antigens 3.7
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 3.69
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.68
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.68
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 3.66
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 3.66
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 3.63
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 3.63
The Human Testis Cell Atlas via Single-cell RNA-seq 3.61
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 3.6
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.59
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.59
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.58
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 3.57
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 3.56
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 3.54
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 3.54
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 3.53
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 3.53
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.5
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 3.49
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.49
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 3.45
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 3.44
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 3.44
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 3.43
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 3.43
The evolution of N6-methyladenosine in primates 3.42
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 3.41
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 3.4
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 3.4
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 3.39
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 3.39
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 3.39
RNA-seq of resting and activated CD4+ T cells +-JQ1 3.39
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.39
Dynamic 3D chromosomal landscapes in acute leukemia 3.39
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 3.37
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 3.36
Targeting MTHFD2 in Acute Myeloid Leukemia 3.36
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.36
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 3.35
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 3.34
Accurate annotation of human protein-coding small open reading frames 3.34
Transcriptome of Stabilin-1 siRNA transfected human monocytes 3.34
Characterization of human ILC2 subsets 3.33
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 3.33
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 3.32
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 3.3
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 3.3
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 3.3
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 3.29
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 3.28
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.25
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 3.24
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.19
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 3.19
RNA sequencing analysis of human embryonic stem cells and axial progenitors 3.17
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 3.17
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 3.17
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.16
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.16
Transciptomic profiling of human fetal lung samples 3.12
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 3.12
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 3.12
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.11
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 3.11
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 3.09
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.09
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.06
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 3.06
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 3.05
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 3.04
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 2.99
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 2.98
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 2.97
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 2.96
RNA-Seq in neutrophils from Antiphospholipid Syndrome 2.95
Spliceosomal disruption of the non-canonical BAF complex in cancer 2.94
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 2.93
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 2.92
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 2.86
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 2.86
Identification of global regulators of T-helper cell lineage specification 2.86
RNA-sequencing 2.83
naive T cell heterogeneity after neonatal thymectomy 2.79
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 2.77
Developmental stage specific chromosome architecture in human erythroid cells 2.77
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.77
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 2.76
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 2.76
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 2.75
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 2.75
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 2.74
Ro60-knockout cells 2.74
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 2.73
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 2.72
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 2.72
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 2.72
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 2.71
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 2.71
Distinct Pathological Signatures in Human Cellular Models of Myotonic Dystrophy Subtypes 2.7
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.69
Transcriptome analysis of SKI knock-out in HL60 cells 2.69
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 2.67
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 2.67
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 2.67
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.64
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.6
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 2.56
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 2.52
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 2.48
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 2.48
A novel target of EZH1/2 for treatment of mantle cell lymphoma 2.47
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 2.45
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.42
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.42
HEK293 TFAM Knockout Expression Study 2.41
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.41
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.41
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 2.4
Neonatal and adult human testis defined at the single-cell level 2.38
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.38
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 2.37
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 2.36
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 2.36
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 2.36
Transcriptomic profiling of human peripheral blood-derived mast cells 2.34
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 2.34
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 2.33
Landscape of H3K4me3 in human CD19 cells 2.33
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.33
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 2.31
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.28
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.28
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 2.27
Hepatosplenic T cell lymphoma 2.27
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 2.27
IRF2 is a master regulator of human keratinocyte stem cell fate 2.27
Transcriptome analysis of peripheral blood monocytes 2.25
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 2.24
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 2.24
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 2.22
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 2.22
Tyrosine Kinase Inhibitor Cardiotoxicity 2.19
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 2.19
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 2.18
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 2.17
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.16
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.16
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 2.14
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 2.13
Transcriptome-wide identification of CELF2 functional targets in T cells 2.04
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.02
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.02
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.98
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.93
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.92
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 1.92
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.91
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.91
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.87
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.83
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 1.82
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 1.82
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.8
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.78
Proliferation-correlated expression 1.74
Primary Human B-cell Temporal Response to CD40L Stimulation 1.72
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 1.72
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.71
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 1.67
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 1.67
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.66
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 1.66
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 1.63
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 1.63
Be1 and Be2 B cells are transcriptionally distinct 1.62
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.6
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.6
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 1.59
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.59
Transcription control by the ENL YEATS domain in acute leukemia 1.59
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 1.57
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 1.57
Transcriptome analysis of human lung epithelial cells 1.56
RNA Seq of Alagille liver biopsies 1.54
Alagille_Nodder 1.54
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 1.53
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.51
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.51
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 1.48
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 1.46
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.45
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.43
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.43
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 1.42
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.42
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.41
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 1.39
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 1.39
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.38
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 1.37
KSDM1b Role in Ewing Sarcoma 1.35
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 1.34
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 1.34
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.33
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.3
Impact on erythroid progenitor type on erythroid differntiation 1.3
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.29
Genome-wide discovery of human splicing branchpoints [RNAse] 1.29
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 1.26
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.25
Dysregulated immune system networks in war veterans with PTSD 1.25
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.24
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.23
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.23
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.21
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 1.21
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 1.16
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.16
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 1.15
Transcriptome sequencing of K-562 cells 1.14
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 1.14
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.11
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 1.08
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 1.06
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.05
Widespread intronic polyadenylation diversifies immune cell transcriptomes 1.03
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.03
Molecular analysis of renal cell carcinoma with unclassfied histology 1.03
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.03
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.03
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.02
Microglia innatly develop within cerebral organoids 1.02
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.02
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 1.01
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 1.01
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.01
RNA Sequencing of Human iPS derived Cardiomyocytes 1.0
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 1.0
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.98
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.96
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.94
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.94
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.94
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.94
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.93
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.92
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.91
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.9
The cytokine environment influence on human skin-derived T cells 0.9
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.88
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 0.87
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 0.87
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 0.86
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.85
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.84
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.84
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.83
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.83
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 0.83
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.8
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.8
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.79
An optimization system for isolating and sequencing of single human colon cancer cells 0.78
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.78
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.77
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.77
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.76
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.75
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.7
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 0.69
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.69
RNA-seq of CD33 KO and control HSPCs 0.66
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.65
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.63
Identification of long noncoding RNAs in T-ALL cell lines 0.61
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.61
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.61
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.59
Modulation of nonsense-mediated decay by rapamycin 0.58
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.57
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.57
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.57
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.55
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 0.54
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 0.52
Targeted enhancer activation by a subunit of the integrator complex 0.52
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.51
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 0.51
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 0.51
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.51
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.51
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.5
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.48
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 0.45
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.42
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.42
The DNA methylation landscape of human melanoma [RNA-Seq] 0.39
The DNA methylation landscape of human melanoma 0.39
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.39
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.39
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.38
The transcriptome and chromatin accessbility landscape of mammalian germline 0.38
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.37
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.37
Gene expression profile of human placenta from T. Cruzi infected mothers 0.37
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.37
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 0.34
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 0.33
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.32
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.32
BET bromodomain inhibition 0.31
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 0.31
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.3
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 0.29
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.28
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.26
Aging-associated patterns in the expression of human endogenous retroviruses 0.25
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.23
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.23
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.21
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.21
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.21
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 0.18
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.18
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.17
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.17
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.16
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.14
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.13
RNA-Seq in PWS iPSC-derived neurons 0.12
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 0.09
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.09
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.09
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.06
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 0.06
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 0.05
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.04
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.02
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.01
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.01
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.01
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.01
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation